These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9000676)

  • 21. Recombinant human interleukin-1 receptor antagonist treatment protects rats from myocardial ischemia-reperfusion injury.
    Zhu J; Huang J; Dai D; Wang X; Gao J; Han W; Zhang R
    Biomed Pharmacother; 2019 Mar; 111():1-5. PubMed ID: 30551029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfo-Lewis(x) diminishes neutrophil infiltration and free radicals with minimal effect on serum cytokines after liver ischemia and reperfusion.
    Garcia-Criado FJ; Palma-Vargas JM; Valdunciel-Garcia JJ; Gomez-Alonso A; Srivastava O; Ezrin A; Anderson MB; Toledo-Pereyra LH
    J Surg Res; 1997 Jul; 70(2):187-94. PubMed ID: 9245570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury.
    Wang ZY; Liu Y; Li SP; Li JJ; Zhang Z; Xiao XC; Ou Y; Wang H; Cai JZ; Yang S
    World J Gastroenterol; 2022 Oct; 28(38):5573-5588. PubMed ID: 36304082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adenosine reduces ischemia/reperfusion-induced liver injury by inhibiting leukocyte activation].
    Harada N; Okajima K; Katsuragi T
    Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():159P-167P. PubMed ID: 10629874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with interleukin-1 receptor antagonist.
    Yang GY; Mao Y; Zhou LF; Ye W; Liu XH; Gong C; Lorris Betz A
    Brain Res Mol Brain Res; 1999 Oct; 72(2):129-37. PubMed ID: 10529471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1 receptor blockade attenuates oxygen-derived free radical production and microcirculatory disturbances in ischemia/reperfusion injury in the liver.
    Shirasugi N; Wakabayashi G; Shimazu M; Shito M; Kawachi S; Kitajima M
    Transplant Proc; 1997; 29(1-2):371-3. PubMed ID: 9123042
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of anti-tumor necrosis factor-alpha in ischemia/reperfusion injury in isolated rat liver in a blood-free environment.
    Ben-Ari Z; Hochhauser E; Burstein I; Papo O; Kaganovsky E; Krasnov T; Vamichkim A; Vidne BA
    Transplantation; 2002 Jun; 73(12):1875-80. PubMed ID: 12131680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ischemic preconditioning on regenerative capacity of hepatocyte in the ischemically damaged rat livers.
    Bedirli A; Kerem M; Pasaoglu H; Erdem O; Ofluoglu E; Sakrak O
    J Surg Res; 2005 May; 125(1):42-8. PubMed ID: 15836849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effect of FR167653 on cold ischemia/reperfusion injury in rat liver transplantation.
    Hashimoto K; Nishizaki T; Yoshizumi T; Uchiyama H; Okano S; Ikegami T; Yanaga K; Sugimachi K
    Transplantation; 2000 Nov; 70(9):1318-22. PubMed ID: 11087146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ryanodine receptor antagonism protects the ischemic liver and modulates TNF-alpha and IL-10.
    López-Neblina F; Toledo-Pereyra LH; Toledo AH; Walsh J
    J Surg Res; 2007 Jun; 140(1):121-8. PubMed ID: 17359999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of aspirin-triggered resolvin D1 on hepatic ischemia/reperfusion injury in rats: The role of miR-146b.
    Zhang T; Xiu HH; Liu JX; Ma Y; Xu KQ; Huang WQ
    Int Immunopharmacol; 2017 Oct; 51():140-147. PubMed ID: 28837866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.
    Dulkanchainun TS; Goss JA; Imagawa DK; Shaw GD; Anselmo DM; Kaldas F; Wang T; Zhao D; Busuttil AA; Kato H; Murray NG; Kupiec-Weglinski JW; Busuttil RW
    Ann Surg; 1998 Jun; 227(6):832-40. PubMed ID: 9637546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin pretreatment exerts anti-inflammatory effects in hepatic ischemia/reperfusion-injured rats via suppression of the TLR2/NF-κB pathway.
    Liu QS; Cheng ZW; Xiong JG; Cheng S; He XF; Li XC
    Transplant Proc; 2015 Mar; 47(2):283-9. PubMed ID: 25769561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
    Harada N; Okajima K; Uchiba M
    Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment with interleukin-33 reduces warm hepatic ischemia/reperfusion injury in mice.
    Li S; Zhu FX; Zhang HB; Li H; An YZ
    Chin Med J (Engl); 2013; 126(10):1855-9. PubMed ID: 23673099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model.
    Bedirli N; Ofluoglu E; Kerem M; Utebey G; Alper M; Yilmazer D; Bedirli A; Ozlu O; Pasaoglu H
    Anesth Analg; 2008 Mar; 106(3):830-7, table of contents. PubMed ID: 18292427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. All-trans retinoic acid preconditioning protects against liver ischemia/reperfusion injury by inhibiting the nuclear factor kappa B signaling pathway.
    Rao J; Qian X; Wang P; Pu L; Zhai Y; Wang X; Zhang F; Lu L
    J Surg Res; 2013 Apr; 180(2):e99-e106. PubMed ID: 22560855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia/reperfusion.
    McCurry KR; Campbell DA; Scales WE; Warren JS; Remick DG
    J Surg Res; 1993 Jul; 55(1):49-54. PubMed ID: 7692134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury.
    Rusai K; Huang H; Sayed N; Strobl M; Roos M; Schmaderer C; Heemann U; Lutz J
    Transpl Int; 2008 Jun; 21(6):572-80. PubMed ID: 18363573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.